Stockreport

Ra Pharma's mid-stage study underway for myasthenia gravis candidate RA101495 SC [Seeking Alpha]

RA PHARMACEUTICALS  (RARX) 
Last ra pharmaceuticals earnings: 11/7 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: rapharma.com/news-investors
PDF Ra Pharma's mid-stage study underway for myasthenia gravis candidate RA101495 SCDosing is underway in a Phase 2 clinical trial evaluating Ra Pharmaceuticals' (NASDAQ:RAR [Read more]